logo
  Join        Login             Stock Quote

Nuvasive (NUVA) Soars After Upbeat Revenue Outlook

 January 09, 2013 10:29 AM
 


(By Balachander) NuVasive Inc. (NASDAQ: NUVA) shares jumped in early trading after the medical device company raised its 2012 revenue forecast and guided 2013 above market expectations.

The California-based company said it expects revenue of roughly $619 million for 2012, up from $601 million to $606 million projected earlier.

Wall Street analysts, on average, expect revenue of $604.4 million for the full year.

For 2013, NuVasive forecasts revenue to be around $655 million, while analysts expect $638.16 million.

The company expects growth in revenue to ramp over the course of the year helped by new product launches and new geographic expansion.

[Related -Stocks Close Higher On Earnings Optimism; Facebook (FB) Jumps]

"Based on our preliminary results, we achieved year over year revenue growth of 15% in 2012, ahead of our initial expectations at the start of the year, and well above our most recent fourth quarter guidance following a soft third quarter," said CEO Alex Lukianov.

The company will announce fourth quarter results on February 26, 2013.

Shares soared 10.79 percent to trade at $17.46 on Wednesday. The stock has been trading between $11.62 and $25.99 over the past year.

Advertisement

Advertisement


Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 

rss feed

Latest Stories

article imageTackling China's Debt Problem: Can Debt-Equity Conversions Help?

China’s high and rising corporate debt problem and how best to address it has received much attention read on...

article imageWill Job Growth Kill The Bear-Market Signal For Stocks?

It’s all about jobs now. Actually, it’s always been about jobs. But the stakes are even higher—perhaps more read on...

article imageAutomating Ourselves To Unemployment

In this current era of central planning, malincentives abound. We raced to frack as fast we could for the read on...

article imageFed: Waiting For June… Or Godot?

The Federal Reserve left interest rates unchanged yesterday, as widely expected. But the possibility of a read on...

Advertisement
Popular Articles

Advertisement
Daily Sector Scan
Partner Center



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.